Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Biotech
Biotech
Page 10 of 18
Health
Not All Biotech Execs Dislike Hillary Clinton
By
Sy Mukherjee
October 18, 2016
Health
Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
By
Sy Mukherjee
October 6, 2016
Tech
Theranos to Shift Focus on Upcoming ‘Minilab’ Device It Will Sell to Clinics
By
Kia Kokalitcheva
October 6, 2016
Health
Samsung’s Biotech Unit Is Seeking Europe Approval for Its Copy of This Drug
By
Reuters
and
Michelle Toh
October 4, 2016
Health
Why Intra-Cellular Therapies’ Stock Got Crushed Today
By
Sy Mukherjee
September 29, 2016
Health
The FDA Just Approved the First Artificial Pancreas for Diabetes
By
Sy Mukherjee
September 28, 2016
Health
First Baby Born Using New Three Parent Technique
By
Sy Mukherjee
September 27, 2016
Health
This Biotech May Get the First Marijuana-Based Therapy Approved in the U.S.
By
Sy Mukherjee
September 26, 2016
Can a Pill Fix Your Hearing?
By
Jennifer Alsever
September 26, 2016
Health
How a Biotech Turned a Bust Into a Hit
By
Jennifer Alsever
September 26, 2016
Health
Mylan Reportedly Paid Its Executives More Than Bigger Rivals
By
Tom Huddleston Jr.
September 14, 2016
Finance
This Biotech Firm Is Eyeing a $700 Million IPO
By
Reuters
and
Michelle Toh
September 14, 2016
Tech
Biogen Drug Shows Early Promise against Alzheimer’s Disease
By
David Z. Morris
September 3, 2016
Leadership
Why Donald Trump’s Anti-Trade Stance Worries Drug Companies
By
Dylan Scott
and
STAT News
August 20, 2016
Health
How GlaxoSmithKline Is Changing the World
By
Sy Mukherjee
August 18, 2016
Most Popular
Politics
The White House has faced a flurry of rejections after inviting 9 universities to be the first signatories of its...
By
Collin Binkley
,
Jonathan Mattise
, and others
Economy
S&P analysis of 9,000 companies worldwide finds the real cost of tariffs and other corporate costs: $1.2 trillion
By
Nino Paoli
Success
Amazon founder Jeff Bezos says ‘millions of people’ will be living in space by 2045—and robots will commute on our...
By
Orianna Rosa Royle